CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Securities Purchase Agreement	Revision of Prior Period, Accounting Standards Update, Adjustment	Common Stock	Common Stock Securities Purchase Agreement	Additional Paid-In Capital	Additional Paid-In Capital Securities Purchase Agreement	Subscription Receivable	Cumulative Translation Adjustment	Accumulated Deficit	Accumulated Deficit Revision of Prior Period, Accounting Standards Update, Adjustment
Beginning balance (in shares) at Dec. 31, 2022				4,625,278
Beginning balance at Dec. 31, 2022	$ (47,047)			$ 0		$ 293,774		$ 0	$ (357)	$ (340,464)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	2,344					2,344
Issuance of shares, net of issuance costs (in shares)				4,144,419
Issuance of shares, net of issuance costs	20,831			$ 1		21,528		(698)
Reverse stock split fractional share adjustment (in shares)				34,538
Restricted shares award issuance, net of withholdings (in shares)				13,684
Issuance of shares for amendment fee associated with debt modification (in shares)				133,333
Issuance of shares for amendment fee associated with debt modification	1,000					1,000
Shares issued in connection with equity exchange agreement (in shares)				180,000
Shares issues in connection with equity exchange agreement	869					869
Issuance of warrants in connection with equity exchange agreement	477					477
Foreign currency translation adjustment	12								12
Net loss	(29,510)									(29,510)
Ending balance (in shares) at Dec. 31, 2023				9,131,252
Ending balance at Dec. 31, 2023	(51,024)			$ 1		319,992		(698)	(345)	(369,974)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	2,182					2,182
Issuance of shares, net of issuance costs (in shares)				1,641,124	450,300
Issuance of shares, net of issuance costs	5,239	$ 1,133		$ 0		4,541	$ 1,133	698
Restricted shares award issuance, net of withholdings (in shares)				300,313
Shares issued in connection with equity exchange agreement (in shares)				810,205
Shares issues in connection with equity exchange agreement	0
Issuance of warrants in connection with equity exchange agreement	4,866					4,866
Issuance of shares in connection with Debt Exchange Agreements (in shares)				692,433
Issuance of shares in connection with Debt Exchange Agreements	1,616					1,616
Foreign currency translation adjustment	(3)								(3)
Net loss	(19,785)									(19,785)
Ending balance (in shares) at Dec. 31, 2024				13,025,627
Ending balance at Dec. 31, 2024	$ (55,754)		$ 22	$ 1		$ 334,330		$ 0	$ (348)	$ (389,737)	$ 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2023-08 [Member]